Prostate cancer has a strong diffusion among men expecially over 60 years old. Despide of this fact the diagnosis and the stages evaluation of the diseases is often difficult to estabilish without using invasive methods e.g: biopsy).
The development of a new test for early stage prostate cancer diagnosis and medium or advanced stage stratifications is one of the target of SANIST personalized medicine approach. Actually, we are validating a new kit, for prostate cancer prevention, in collaboration with Multimedica laboratory and other research centers. The details od the SANIST prostate cancer prevention methods have been published on the peer-reviewed journal “Frontiers in Endocrinology”. Click here to download the open access publication.